Cyclic HGH Fragment (176-191)

Growth Hormone peptide HGH Fragment 176-191 is a synthetic modified form of the GH polypeptide’s amino acids 176-191. Research carried out by scientists at Monash University revealed that the ability of GH to reduce fat was regulated by a small region close to the end of the GH Molecule. This small region contains amino acids 177-191, which make up under 10 percent of the entire volume of the GH molecule. The region has no visible effect on growth resistance or insulin resistance. The way it functions is by replicating how the Natural Growth Hormone regulates Fat metabolism, minus the harmful effects observed with unmodified Growth Hormone.

This product is for research use only.

Cyclic HGH Fragment (176-191) is a 16-residue synthetic peptide with the sequence Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe. The sequence contains 2 cysteine residues, providing potential thiol/disulfide chemistry when the thiol is available. These sequence-derived properties describe the reagent chemically; no specific receptor, enzyme, pathway, disease association, or biological activity is assigned without product-specific experimental evidence.

• thiol-selective conjugation or immobilization studies
• LC-MS/HPLC analytical method development
• sequence-specific assay controls

Sequence-derived chemical properties support reagent selection and experimental planning but do not establish biological function. Solubility, aggregation, adsorption, conjugation efficiency, and assay performance should be validated under the intended experimental conditions.